Home LiteratureArticle Details
PMID: 18583555 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study.

Stroke ·Vol. 39 ·No. 11 ·2008-11-00 ·Pages 2929-35

Das RR, Seshadri S, Beiser AS, Kelly-Hayes M, Au R, Himali JJ, Kase CS, Benjamin EJ, Polak JF, O'Donnell CJ, Yoshita M, D'Agostino RB, DeCarli C, Wolf PA

Abstract

Previous estimates of the prevalence of silent cerebral infarction (SCI) on MRI in community-based samples have varied between 5.8% and 17.7% depending on age, ethnicity, presence of comorbidities, and imaging techniques. We document the prevalence and risk factors associated with SCI at midlife in the community-based Framingham sample. Our study sample comprised 2040 Framingham Offspring (53% female; mean age, 62+/-9 years) who attended the sixth examination (1996-1998), underwent volumetric brain MRI (1999-2005,) and were free of clinical stroke at MRI. We examined the age- and sex-specific prevalences and the clinical correlates of SCI using multivariable logistic regression models. At least 1 SCI was present in 10.7% of participants; 84% had a single lesion. SCI was largely located in the basal ganglia (52%), other subcortical (35%) areas, and cortical areas (11%). Prevalent SCI was associated with the Framingham Stroke Risk Profile score (OR, 1.27; 95% CI, 1.10-1.46); stage I hypertension was determined by JNC-7 criteria (OR,1.56; CI,1.15-2.11), an elevated plasma homocysteine in the highest quartile (OR, 2.23; CI, 1.42-3.51), atrial fibrillation (OR, 2.16; CI, 1.07-4.40), carotid stenosis >25% (OR, 1.62; 1.13-2.34), and increased carotid intimal-medial thickness above the lowest quintile (OR, 1.65; CI, 1.22-2.24). The prevalence and distribution of SCI in the Framingham Offspring are comparable to previous estimates. Risk factors previously associated with clinical stroke were also found to be associated with midlife SCI. Our results support current guidelines emphasizing early detection and treatment of stroke risk factors.

MeSH Terms
Age Factors Aged Cerebral Infarction/epidemiology,pathology Family Female Humans Longitudinal Studies Magnetic Resonance Imaging Male Massachusetts/epidemiology Middle Aged Regression Analysis Risk Factors Sex Factors
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Das Rohit R
Department of Neurology, Boston University, Boston, MA 02118, USA.
Seshadri Sudha
Beiser Alexa S
Kelly-Hayes Margaret
Au Rhoda
Himali Jayandra J
Kase Carlos S
Benjamin Emelia J
Polak Joseph F
O'Donnell Christopher J
Yoshita Mitsuhiro
D'Agostino Ralph B
DeCarli Charles
Wolf Philip A
References (46)
46 references, click to expand
  1. Silent brain infarction in nonrheumatic atrial fibrillation. EAFT Study Group. European Atrial Fibrillation Trial.
    Neurology. 1996 Jan;46(1):159-65 PMID: 8559367
  2. Prevention of stroke.
    Lancet. 1998 Oct;352 Suppl 3:SIII15-8 PMID: 9803957
  3. Silent cerebral infarction in chronic atrial fibrillation.
    Stroke. 1987 Nov-Dec;18(6):1098-100 PMID: 3686584
  4. Silent stroke in the NINCDS Stroke Data Bank.
    Neurology. 1988 Nov;38(11):1674-9 PMID: 3185900
  5. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group.
    Stroke. 1997 Jun;28(6):1158-64 PMID: 9183343
  6. Prevalence and risk factors of silent cerebral infarction in apparently normal adults.
    Hypertension. 2000 Jul;36(1):73-7 PMID: 10904015
  7. Asymptomatic carotid bruit and risk of stroke. The Framingham study.
    JAMA. 1981 Apr 10;245(14):1442-5 PMID: 7206146
  8. Comparison of probability of stroke between the Copenhagen City Heart Study and the Framingham Study.
    Stroke. 1994 Apr;25(4):802-7 PMID: 8160224
  9. Epidemiological approaches to heart disease: the Framingham Study.
    Am J Public Health Nations Health. 1951 Mar;41(3):279-81 PMID: 14819398
  10. Asymptomatic cerebral infarction in patients with chronic atrial fibrillation.
    Stroke. 1988 Aug;19(8):955-7 PMID: 3400107
  11. Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation.
    Arch Intern Med. 1990 Nov;150(11):2340-4 PMID: 2241443
  12. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study.
    Ann Neurol. 2002 Mar;51(3):285-9 PMID: 11891822
  13. Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study.
    Stroke. 1995 Mar;26(3):380-5 PMID: 7886710
  14. An investigation of coronary heart disease in families. The Framingham offspring study.
    Am J Epidemiol. 1979 Sep;110(3):281-90 PMID: 474565
  15. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.
    Stroke. 2004 Aug;35(8):1857-61 PMID: 15218158
  16. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study.
    Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1662-7 PMID: 12377746
  17. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.
    Circulation. 1995 Oct 15;92(8):2178-82 PMID: 7554199
  18. Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults : the Cardiovascular Health Study. CHS Collaborative Research Group.
    Arterioscler Thromb Vasc Biol. 1999 Feb;19(2):356-65 PMID: 9974419
  19. Silent stroke: pathogenesis, genetic factors and clinical implications as a risk factor.
    Curr Opin Neurol. 2001 Feb;14(1):77-82 PMID: 11176221
  20. Insulin resistance is related to silent cerebral infarction in patients with essential hypertension.
    Am J Hypertens. 1997 Nov;10(11):1245-9 PMID: 9397243
  21. Silent stroke and carotid stenosis.
    Stroke. 1992 Apr;23(4):483-5 PMID: 1561676
  22. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal.
    Neurobiol Aging. 2005 Apr;26(4):491-510 PMID: 15653178
  23. Probability of stroke: a risk profile from the Framingham Study.
    Stroke. 1991 Mar;22(3):312-8 PMID: 2003301
  24. Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia.
    Stroke. 1999 Feb;30(2):378-82 PMID: 9933274
  25. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years.
    JAMA. 2006 Dec 27;296(24):2939-46 PMID: 17190894
  26. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors.
    Stroke. 1986 Nov-Dec;17(6):1084-9 PMID: 3810705
  27. Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people.
    Stroke. 2001 May;32(5):1116-9 PMID: 11340219
  28. Cigarette smoking and other risk factors for silent cerebral infarction in the general population.
    Stroke. 1998 May;29(5):913-7 PMID: 9596234
  29. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.
    N Engl J Med. 2002 Feb 14;346(7):476-83 PMID: 11844848
  30. Carotid turbulent flow observed by convergent color Doppler flowmetry in silent cerebral infarction.
    Int J Cardiovasc Imaging. 2002 Apr;18(2):119-24 PMID: 12108907
  31. The occurrence of lung cancer in man.
    Acta Unio Int Contra Cancrum. 1953;9(3):531-41 PMID: 13124110
  32. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS).
    Stroke. 2006 Jan;37(1):87-92 PMID: 16339465
  33. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study.
    Stroke. 1994 Jan;25(1):40-3 PMID: 8266381
  34. Silent brain infarcts: a systematic review.
    Lancet Neurol. 2007 Jul;6(7):611-9 PMID: 17582361
  35. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.
    N Engl J Med. 1999 Jan 7;340(1):14-22 PMID: 9878640
  36. Homocysteine and cognitive performance in the Framingham offspring study: age is important.
    Am J Epidemiol. 2005 Oct 1;162(7):644-53 PMID: 16107567
  37. Silent brain infarcts and the risk of dementia and cognitive decline.
    N Engl J Med. 2003 Mar 27;348(13):1215-22 PMID: 12660385
  38. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study.
    Stroke. 2002 Jan;33(1):21-5 PMID: 11779883
  39. LACUNES: SMALL, DEEP CEREBRAL INFARCTS.
    Neurology. 1965 Aug;15:774-84 PMID: 14315302
  40. Search for an optimal atherogenic lipid risk profile: from the Framingham Study.
    Am J Cardiol. 2006 Feb 1;97(3):372-5 PMID: 16442398
  41. Annual incidence of first silent stroke in the United States: a preliminary estimate.
    Cerebrovasc Dis. 2003;16(3):280-5 PMID: 12865617
  42. Baseline silent cerebral infarction in the Asymptomatic Carotid Atherosclerosis Study.
    Stroke. 1994 Jun;25(6):1122-9 PMID: 8202968
  43. Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions: the Framingham Heart Study.
    J Am Coll Cardiol. 2005 Mar 1;45(5):685-9 PMID: 15734611
  44. Diffusion-weighted MR imaging in transient ischaemic attacks.
    Eur Radiol. 2006 May;16(5):1090-5 PMID: 16395534
  45. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people.
    Stroke. 2006 Feb;37(2):466-70 PMID: 16373631
  46. Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study.
    Neurology. 2008 Feb 5;70(6):425-30 PMID: 17898325
Article Info
Journal
Stroke
Abbr.
Stroke
ISSN
1524-4628
Published
2008-11-00
Epub
2008-00-26
Pages
2929-35
Language
English
Region
United States
NLM ID
0235266
PMCID
PMC2712254
Subset
IM
Grants
NHLBI NIH HHS · N01-HC-25195 · United States
NINDS NIH HHS · R01 NS017950 · United States
NIA NIH HHS · R01 AG016495 · United States
NIA NIH HHS · R01 AG016495-10 · United States
NIA NIH HHS · AG08122 · United States
NIA NIH HHS · P30 AG010129-18 · United States
NIA NIH HHS · R01 AG008122 · United States
NINDS NIH HHS · R01 NS017950-27 · United States
NIA NIH HHS · P30 AG010129 · United States
NIA NIH HHS · R01 AG16495 · United States
NINDS NIH HHS · R01 NS17950 · United States
NHLBI NIH HHS · N01 HC025195 · United States
NIA NIH HHS · R01 AG008122-19 · United States
NHLBI NIH HHS · N01HC25195 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]